Updates From The CLI Global Society – Goals For 2020 And Beyond
The Critical Limb Ischemia Global Society (CLIGS) is a 501(c)(6) nonprofit organization founded in 2016 by Alan T. Hirsch, MD; Michael R. Jaff, DO; Barry T. Katzen, MD; J…
The Critical Limb Ischemia Global Society (CLIGS) is a 501(c)(6) nonprofit organization founded in 2016 by Alan T. Hirsch, MD; Michael R. Jaff, DO; Barry T. Katzen, MD; J…
Despite recent guideline updates on peripheral artery disease (PAD) and critical limb ischemia (CLI) treatment, the optimal treatment for CLI is still being debated. As a r…
Few studies have compared long-term outcomes among specific treatment modalities for critical limb ischemia. The aim of this study was to compare long-term outcomes with pe…
Peripheral artery disease (PAD) of the lower extremities is a global pandemic of growing proportions. Between 2000 and 2010, the world’s population increased by 12.6%, an…
Critical limb ischemia (CLI) represents the final stages of peripheral artery disease, reflecting impairment in tissue perfusion that leads to a threatened limb. The clinic…
The optimal treatment for critical limb ischemia remains controversial owing to conflicting conclusions from previous studies. We obtained administrative claims on Med…